Brookstone Capital Management »

Leap Therapeutics shares owned by Brookstone Capital Management

Quarter-by-quarter ownership of Leap Therapeutics (CYPH) shares owned by Brookstone Capital Management from 13F filings

Historical chart of Brookstone Capital Management investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Brookstone Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Brookstone Capital Management

Quarter filed Position value Share count Share price at filing
2026-09-30 $50k 15k 3.33

More positions owned by Brookstone Capital Management

Vanguard Index Fds Mrngstr Val Etf (VTV)
Vanguard Index Fds Mrngstr Grwt Etf (VUG)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Microsoft Corporation Put Option (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Northern Lts Fd Tr Iv Brookstone Grwth (BAMG)
Vanguard Wellington Us Multifactor (VFMF)
Northern Lts Fd Tr Iv Broo Valu St Etf (BAMV)
Ishares Tr Core Us Aggbd Et (AGG)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Brookstone Capital Management

Top funds holding Leap Therapeutics

Vanguard Capital Management
BlackRock
Jane Street
Citadel Advisors
Geode Capital Management
UBS Group
Susquehanna International
XTX Topco
Vanguard Fiduciary Trust
State Street Corporation
SLT Holdings
Cygnus Capital Advisors
Northern Trust
LPL Financial
Sequoia Financial Advisors

View all funds holding Leap Therapeutics